Singapore markets close in 7 hours 16 minutes
Straits Times Index
3,324.29 +31.60 (+0.96%) Nikkei
38,127.92 -146.13 (-0.38%) Hang Seng
17,760.68 -2.35 (-0.01%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,021.44 -3,245.11 (-5.38%) CMC Crypto 200
1,266.18 -72.89 (-5.44%)
ABT Jan 2026 105.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:04PM EDT. Market open.
| Previous close | 9.13 |
| Open | 9.00 |
| Bid | 8.95 |
| Ask | 9.30 |
| Strike | 105.00 |
| Expiry date | 2026-01-16 |
| Day's range | 8.90 - 9.05 |
| Contract range | N/A |
| Volume | |
| Open interest | 284 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.